Cargando…
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for the treatment of many parasitic diseases such as river blindness, elephantiasis and scabies. Satoshi ōmura and William C. Campbell won the 2015 Nobel Prize in Physiology or Medicine for the discovery of the...
Autores principales: | Tang, Mingyang, Hu, Xiaodong, Wang, Yi, Yao, Xin, Zhang, Wei, Yu, Chenying, Cheng, Fuying, Li, Jiangyan, Fang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/ https://www.ncbi.nlm.nih.gov/pubmed/32971268 http://dx.doi.org/10.1016/j.phrs.2020.105207 |
Ejemplares similares
-
Pharmacokinetics of tenvermectin in swine, a novel antiparasitic drug candidate—comparison with ivermectin
por: Li, Guiyu, et al.
Publicado: (2023) -
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022) -
Nanoparticles for antiparasitic drug delivery
por: Sun, Yuzhu, et al.
Publicado: (2019) -
Antifungal and Antiparasitic Drug Delivery
por: Torrado, Juan José, et al.
Publicado: (2020) -
Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs
por: Branco Santos, Joice Castelo, et al.
Publicado: (2020)